Clinical Trial Update: CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating CAPOX in KRAS wild-type advanced adenocarcinoma of the small bowel or ampulla of Vater; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampulla of Vater Cancer
• Gastrointestinal Cancer
• Small Bowel Cancer

Drugs mentioned

• CAPOX (capecitabine + oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Gastrointestinal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-02-21